We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Shenandoah CTGrade GMP rh IFN-gamma is a recombinant human protein produced from E. coli and is designed to support basic, translational, and clinical research, as well as commercial applications.
Size: 50 µg, 100 µg, and 1 mg. Custom sizes and packaging available on request.
Interferon-gamma (IFN-γ), also known as type II or immune interferon, is a macrophage-activating cytokine with broad immune-regulatory functions and is considered the prototype pro-inflammatory cytokine. It is primarily produced by T lymphocytes and natural killer (NK) cells in response to antigens, mitogens, and other cytokines.
The biological activity of CTGrade GMP interleukins and growth factors is standardized, where applicable, to WHO International standards, providing cell and gene therapy developers consistent, lot-to-lot biological activity and performance.
CTGrade GMP products are manufactured in a facility that does not use or process beta-lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. These products are manufactured, tested, and released in an ISO 9001:2015 certified facility following GMP. USP chapter <1043> for ancillary materials has been considered in the manufacture of these products.


Figure 1. CTGrade GMP rh IFN-gamma (1 μg) was resolved with SDS-PAGE under non-reducing (NR) and reducing (R) conditions and visualized by Instant Blue staining showing a single prominent band at 16.9 kDa.


Figure 2. The biological activity of CTGrade GMP rh IFN-gamma was determined in a cell proliferation assay using HT-29 cells.


Figure 3. CTGrade GMP rh IFN-gamma induces proliferation in HT-29 cells that is consistent between lots.


Figure 4. Bioactivity comparison between CTGrade GMP rh IFN-gamma and commercially-available rh CTGrade GMP rh IFN-gamma.
| Formulation | CTGrade GMP rh IFN-gamma is lyophilized from a 0.2 μm filtered solution containing 20 mM Sodium Phosphate, 2% Trehalose, 4% Mannitol, 0.1 % Tween 80, pH 6.5 |
| Protein Purity | ≥ 98% determined by reducing and non-reducing SDS-PAGE analysis |
| Endotoxin | < 0.01 EU/μg using USP <85> / EP 2.6.14 |
| Bioactivity | ED50 is determined by the dose-dependent cytotoxicity of HT-29 cells by rh IFN-gamma cells. The ED50 is typically less than 0.3 ng/mL. |
| Quality | Carrier-free and no animal- or human-derived materials were used during manufacturing |